Summary of Key Points Core Viewpoint - The company, HAPO Pharmaceutical-B, has been actively repurchasing its shares, indicating a strategy to support its stock price amidst recent declines [2][3]. Share Buyback Activity - On October 13, the company repurchased 250,000 shares at prices ranging from HKD 13.280 to HKD 13.460, totaling HKD 3.344 million [2]. - The stock closed at HKD 13.350 on the same day, reflecting a decline of 5.45%, with a total trading volume of HKD 225 million [2]. - Since October 9, the company has conducted buybacks for three consecutive days, accumulating a total of 500,000 shares repurchased for HKD 6.944 million, during which the stock price fell by 18.99% [2]. Year-to-Date Buyback Summary - Year-to-date, the company has executed 50 buybacks, totaling 22.093 million shares and an aggregate amount of HKD 14.730 million [3]. - The detailed buyback activities include various dates, share quantities, and price ranges, showcasing a consistent effort to stabilize the stock price [4].
和铂医药-B(02142.HK)连续3日回购，累计回购50.00万股